
CNS Pharmaceuticals, Inc. (CNSP)
- Previous Close
5.78 - Open
5.77 - Bid 4.03 x 200
- Ask 7.61 x 200
- Day's Range
5.77 - 5.89 - 52 Week Range
1.90 - 10.59 - Volume
1,450 - Avg. Volume
11,352 - Market Cap (intraday)
8.611M - Beta (5Y Monthly) 0.98
- PE Ratio (TTM)
-- - EPS (TTM)
-15.39 - Earnings Date (est.) --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.00
Recent News
View MorePerformance Overview
Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
8.06M
-
Enterprise Value
5.34M
-
Trailing P/E
0.00
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
0.44
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-58.01%
-
Return on Equity (ttm)
-106.62%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-16.7M
-
Diluted EPS (ttm)
-15.39
Balance Sheet and Cash Flow
-
Total Cash (mrq)
19.98M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-7.94M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
